A phase 2a trial shows tigilanol tiglate achieves an 80% response rate in soft tissue sarcoma, offering hope for effective ...

Sarcoma Awareness Month sheds light on rare cancers, emphasizing early detection, research advancement, and patient support.

Sarcoma UK is encouraging people to act quickly when they notice potential symptoms, such as a lump that is growing or ...

Heat-triggered release mechanism unequivocally confirmedFavorable safety profile with good tolerability Signs of encouraging ...

The trial enrolled 49 patients with mTLS-negative STS, including leiomyosarcoma (45%) and synovial sarcoma (18%). The ...

“In terms of breast cancer, lung cancer and bowel cancer, it’s very obvious where they come from, whereas the word sarcomas ...

Positive data from Stage 1 of the Phase IIa clinical trial (QB46C-H07) evaluating QBiotics' small molecule, tigilanol tiglate ...

There are many different subtypes of sarcomas, but they are generally grouped into two main categories. “The main types are sarcomas of bone and sarcomas of soft tissue,” explains Stradling.

Sarcoma is a type of cancer that originates in the bones or soft tissue. Soft tissue sarcoma (STS) most often begins in the arms and legs but can also occur in other body parts.

There are many different subtypes of sarcomas, but they are generally grouped into two main categories. “The main types are sarcomas of bone and sarcomas of soft tissue,” explains Stradling.